Pharma & Biotech

The fate of Xoma Royalty's proposed acquisition of LAVA Therapeutics hangs in the balance as shareholders convene for a decisive...

Though ImmunoGen ceased to exist as an independent entity following its acquisition by AbbVie in February 2024, the company's scientific...

The Danish pharmaceutical company renowned for its diabetes and obesity treatments finds itself navigating turbulent waters. Novo Nordisk has been...

The shares of French biotechnology firm Valneva are exhibiting the characteristic volatility that defines the sector, swinging between investor optimism...

Biopharmaceutical firm Veru is presenting fresh clinical findings for its drug candidate Enobosarm at the ObesityWeek 2025 conference today. The...

Shares of Arcturus Therapeutics are experiencing a severe downturn, weighed down by a combination of disappointing quarterly projections and newly...

Investors are driving a robust recovery in Akebia Therapeutics stock following a period of significant pressure. The resurgence is fueled...

BioAtla Inc. witnessed a powerful surge in its stock price today following the release of unexpectedly robust clinical trial results....

When a medical technology company delivers explosive earnings that shatter expectations yet sees its shares lose momentum, investors face a...

Trevi Therapeutics shares are demonstrating remarkable momentum with a sustained upward trajectory that has captured market attention. In the latest...